{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:46:59Z","timestamp":1762876019230,"version":"build-2065373602"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.atherosclerosis.2018.06.012","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T09:46:05Z","timestamp":1538127965000},"page":"407-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Establishing a national screening programme for familial hypercholesterolaemia in Lithuania"],"prefix":"10.1016","volume":"277","author":[{"given":"Zaneta","family":"Petrulioniene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urte","family":"Gargalskaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0806-4925","authenticated-orcid":false,"given":"Sandra","family":"Kutkiene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justina","family":"Staigyte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimante","family":"Cerkauskiene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandras","family":"Laucevicius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(02)00330-1","article-title":"A\u00a0review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia","volume":"168","author":"Marks","year":"2003","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.06.012_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/aje\/kwh236","article-title":"Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review","volume":"160","author":"Austin","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib3","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/eurheartj\/ehn448","article-title":"Familial hypercholesterolaemia: underdiagnosed and undertreated","volume":"29","author":"Rees","year":"2008","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.06.012_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.atherosclerosis.2015.06.050","article-title":"Consensus Panel statement on homozygous FH","volume":"242","author":"Stock","year":"2015","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2018.06.012_bib5","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2018.06.012_bib6","first-page":"464","article-title":"Familial hypercholesterolemia: clues to catching it early","volume":"64","author":"Safeer","year":"2015","journal-title":"J.\u00a0Fam. Pract."},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijcard.2013.11.025","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation","volume":"171","author":"Watts","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"issue":"7254","key":"10.1016\/j.atherosclerosis.2018.06.012_bib9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/bmj.321.7254.148","article-title":"Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study","volume":"321","author":"Neil","year":"2000","journal-title":"BMJ"},{"year":"2008","series-title":"Clinical Guidelines and Evidence Review for Familial Hypercholesterolaemia: the Identification and Management of Adults and Children with Familial Hypercholesterolaemia","author":"DeMott","key":"10.1016\/j.atherosclerosis.2018.06.012_bib10"},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0021-9150(98)00200-7","article-title":"Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management","volume":"142","author":"Scientific Steering Committee on behalf of the Simon Broome Register Group","year":"1999","journal-title":"Atherosclerosis"},{"issue":"Pt 6","key":"10.1016\/j.atherosclerosis.2018.06.012_bib12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1258\/acb.2012.012002","article-title":"Opportunistic screening for familial hypercholesterolaemia via a community laboratory","volume":"49","author":"Bell","year":"2012","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib13","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.jacl.2011.03.452","article-title":"National lipid association expert panel on familial hypercholesterolemia. Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the national lipid association expert panel on familial hypercholesterolemia","volume":"5","author":"Hopkins","year":"2011","journal-title":"J.\u00a0Clin.Lipidol."},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Risk of fatal coronary heart disease in familial hypercholesterolaemia","volume":"303","author":"Scientific Steering Committee of behalf of Simon Broome Register Group","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolaemia using new practical criteria validated by molecular genetics","volume":"72","author":"Williams","year":"1993","journal-title":"Am. J. Cardiol."},{"year":"1999","series-title":"Familial Hypercholesterolaemia (FH): Report of a Second WHO Consultation","author":"World Health Organisation","key":"10.1016\/j.atherosclerosis.2018.06.012_bib16"},{"year":"2017","series-title":"Causes of death 2016","key":"10.1016\/j.atherosclerosis.2018.06.012_bib17"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.06.012_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2217\/clp.15.16","article-title":"The prevalence of dislipidemia and its relation to other risk factors: a nationwide survey of Lithuania","volume":"10","author":"Rinkuniene","year":"2015","journal-title":"J.\u00a0Clin.Lipidol."},{"year":"2017","series-title":"Causes of death \u2013 standardized death rate, 2014 [Datafile]","author":"Eurostat","key":"10.1016\/j.atherosclerosis.2018.06.012_bib19"},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/PAT.0b013e32834efa07","article-title":"Screening for familial hypercholesterolaemia","volume":"44","author":"Bender","year":"2012","journal-title":"Pathology"},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib21","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/bmj.324.7349.1303","article-title":"Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia","volume":"324","author":"Marks","year":"2002","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.06.012_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jama.2017.8543","article-title":"Cascade screening for familial hypercholesterolemia and the use of genetic testing","volume":"318","author":"Knowles","year":"2017","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cca.2013.03.027","article-title":"Impact of interpretative commenting on lipid profiles in people at high risk of familial hypercholesterolaemia","volume":"422","author":"Bell","year":"2013","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.06.012_bib24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCGENETICS.111.962456","article-title":"Discriminative ability of LDL-cholesterol to identify patients with familial hypercholesterolemia: a cross-sectional study in 26,406 individuals tested for genetic FH","volume":"5","author":"Huijgen","year":"2012","journal-title":"Circ.Cardiovasc.Genet."},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib25","first-page":"3","article-title":"Lithuanian high cardiovascular risk (LitHiR) primary prevention programme \u2013 rationale and design","volume":"18","author":"Laucevicius","year":"2012","journal-title":"Semin.Cardiovasc. Med."},{"issue":"29","key":"10.1016\/j.atherosclerosis.2018.06.012_bib26","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib27","unstructured":"The Lithuanian Department of Statistics, Vilnius; 2017."},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib28","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2017-02622","article-title":"A\u00a0comparative analysis of phenotypic predictors of mutations in familial hypercholesterolemia","author":"Chan","year":"2018","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.06.012_bib29","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/MOL.0000000000000300","article-title":"A\u00a0systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries","volume":"27","author":"Mundal","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.atherosclerosis.2015.09.021","article-title":"Familial hypercholesterolaemia: a global call to arms","volume":"243","author":"Vallejo-Vaz","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib31","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2015.07.017","article-title":"Universal screening for familial hypercholesterolemia in children","volume":"66","author":"Klan\u010dar","year":"2015","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.06.012_bib32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.5551\/jat.34108","article-title":"International developments in the care of familial hypercholesterolemia: where now and where to next?","volume":"23","author":"Pang","year":"2016","journal-title":"J.\u00a0Atherosclerosis Thromb."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2018.06.012_bib33","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.5551\/jat.37507","article-title":"Design of the familial hypercholesterolaemia australasia network registry: creating opportunities for greater international collaboration","volume":"24","author":"Bellgard","year":"2017","journal-title":"J.\u00a0Atherosclerosis Thromb."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.06.012_bib34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jacl.2010.08.022","article-title":"Defining the challenges of FH screening for familial hypercholesterolemia","volume":"4","author":"Defesche","year":"2010","journal-title":"J.\u00a0Clin.Lipidol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.06.012_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.36290\/vnl.2017.005","article-title":"ScreenPro FH - screening project for familial hypercholesterolemia in central, southern and eastern Europe: basic epidemiology","volume":"63","author":"\u010ce\u0161ka","year":"2017","journal-title":"Vnitr. Lek."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2018.06.012_bib36","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.amjcard.2008.06.056","article-title":"Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia","volume":"102","author":"Civeira","year":"2008","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2018.06.012_bib37","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.atherosclerosis.2014.12.034","article-title":"Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)","volume":"238","author":"Weng","year":"2015","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2018.06.012_bib38","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/heartjnl-2015-308824","article-title":"A\u00a0new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice","volume":"102","author":"Troeung","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib39","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/hrt.2006.107391","article-title":"Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre","volume":"94","author":"Gray","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib40","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.hlc.2014.09.011","article-title":"Systematic detection of familial hypercholesterolaemia in primary health care: a community based prospective study of three methods","volume":"24","author":"Kirke","year":"2015","journal-title":"Heart Lung Circ."},{"issue":"29","key":"10.1016\/j.atherosclerosis.2018.06.012_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta4290","article-title":"Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis","volume":"4","author":"Marks","year":"2000","journal-title":"Health Technol. Assess."},{"issue":"23","key":"10.1016\/j.atherosclerosis.2018.06.012_bib42","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/eurheartj\/ehx111","article-title":"Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK","volume":"38","author":"Kerr","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a1095","article-title":"Familial hypercholesterolaemia: summary of NICE guidance","volume":"337","author":"Wierzbicki","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.06.012_bib44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.atherosclerosis.2004.12.001","article-title":"The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population","volume":"180","author":"Damgaard","year":"2005","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.06.012_bib45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/MOL.0000000000000173","article-title":"Improving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemia","volume":"26","author":"Pears","year":"2015","journal-title":"Curr. Opin. Lipidol."},{"issue":"Pt 4","key":"10.1016\/j.atherosclerosis.2018.06.012_bib46","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1469-1809.2008.00436.x","article-title":"Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database","volume":"72","author":"Leigh","year":"2008","journal-title":"Ann. Hum. Genet."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.06.012_bib47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0021-9150(03)00233-8","article-title":"Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study","volume":"170","author":"Neil","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib48","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.atherosclerosissup.2011.06.001","article-title":"Familial hypercholesterolaemia: a model of care for Australasia","volume":"12","author":"Watts","year":"2011","journal-title":"Atherosclerosis Suppl."},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib49","article-title":"Feasibility of improving identification of familial hypercholesterolaemia in general practice: intervention development study","volume":"6","author":"Qureshi","year":"2016","journal-title":"Br. Med. J.Open"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2018.06.012_bib50","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.hlc.2014.06.015","article-title":"Can patients be accurately assessed for familial hypercholesterolaemia in primary care?","volume":"23","author":"Bell","year":"2014","journal-title":"Heart Lung Circ."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.06.012_bib51","first-page":"26","article-title":"Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening","volume":"11","author":"Leren","year":"2008","journal-title":"Community Genet."},{"key":"10.1016\/j.atherosclerosis.2018.06.012_bib52","article-title":"Detection\u2028and management of familial hypercholesterolaemia in primary care in Australia: protocol for a pragmatic cluster intervention study\u2028with pre-post intervention comparisons","volume":"7","author":"Arnold-Reed","year":"2017","journal-title":"Br. Med. J.Open"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018303228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018303228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:38:00Z","timestamp":1758155880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915018303228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":52,"alternative-id":["S0021915018303228"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.06.012","relation":{},"ISSN":["0021-9150"],"issn-type":[{"type":"print","value":"0021-9150"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishing a national screening programme for familial hypercholesterolaemia in Lithuania","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}